Table 1

Patient characteristics (N = 201) according to surgical approach

CharacteristicNo. (%)* of patients treated with 2p-VATSNo. (%)* of patients treated with 3p-VATSNo. (%)* of patients treated with Sx-VATSp value
Total97 (48.3)87 (43.2)17 (8.5)
Age, yr, mean ± IQR68 ± 10.069 ± 9.167 ± 11.50.82
Gender0.30
 Male42 (43.3)38 (43.7)4 (23.5)
 Female52 (56.7)49 (56.3)13 (76.5)
Charlson Comorbidity Index, mean ± IQR5.2 ± 1.95.6 ± 2.14.9 ± 1.40.34
FEV1, mean ± IQR82.9 ± 29.884.5 ± 17.582.1 ± 24.60.12
DLCO, mean ± IQR76.9 ± 27.575.7 ± 16.864.6 ± 17.70.73
Active smoking, mean ± IQR23 ± 21.927 ± 30.06 ± 33.30.29
BMI, mean ± IQR27.7 ± 5.627.4 ± 4.626.5 ± 4.20.32
Histology0.39
 Adenocarcinoma58 (59.8)52 (59.8)13 (76.5)
 Squamous cell carcinoma11 (11.3)17 (19.5)1 (5.9)
 Other28 (28.9)18 (20.7)3 (17.6)
Pathological staging0.50
 I72 (74.2)65 (74.7)15 (88.2)
 II18 (18.6)15 (17.2)0 (0.0)
 IIIa7 (7.2)7 (8.0)2 (11.8)
Surgery type0.35
Lobectomy86 (88.7)83 (95.4)15 (88.2)
Segmentectomy11 (11.3)4 (4.6)2 (11.8)
  • 2p-, 3p-, Sx-VATS = 2-port, 3-port, or subxiphoid video-assisted thoracic surgery; BMI = body mass Index; DLCO = diffusing capacity for carbon monoxide; FEV1 = forced expiratory volume in 1 second; IQR = interquartile range.

  • * Unless otherwise specified.